Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer's dementia: a randomized controlled trial.

Randomized controlled trial · Alzheimers Res Ther · 2023. Source record refreshed; an explanation has not been reviewed.

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Wunderlich G, Blahova Z, Garcia M et al.
Alzheimers Res Ther · 2023

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.